Kanojia N - Search Results

1

Insights into the pivotal role of statins and its nanoformulations in hyperlipidemia.

Singh S, Zahoor I, Sharma N, Behl T, Kanojia N, Sehgal A, Mohan S, Almoshari Y, Salawi A, Aleya L, Bungau S. Singh S, et al. Among authors: kanojia n. Environ Sci Pollut Res Int. 2022 Nov;29(51):76514-76531. doi: 10.1007/s11356-022-23043-3. Epub 2022 Sep 26. Environ Sci Pollut Res Int. 2022. PMID: 36161571 Review.

2

Natural Compounds as Source of Aldose Reductase (AR) Inhibitors for the Treatment of Diabetic Complications: A Mini Review.

Grewal AS, Thapa K, Kanojia N, Sharma N, Singh S. Grewal AS, et al. Among authors: kanojia n. Curr Drug Metab. 2020;21(14):1091-1116. doi: 10.2174/1389200221666201016124125. Curr Drug Metab. 2020. PMID: 33069193 Review.

3

Alcoholic and Non-Alcoholic Liver Diseases: Promising Molecular Drug Targets and their Clinical Development.

Thapa K, Grewal AS, Kanojia N, Rani L, Sharma N, Singh S. Thapa K, et al. Among authors: kanojia n. Curr Drug Discov Technol. 2021;18(3):333-353. doi: 10.2174/1570163817666200121143959. Curr Drug Discov Technol. 2021. PMID: 31965945 Review.

4

Therapeutic Insights on Ferroptosis in Parkinson's disease.

Thapa K, Khan H, Kanojia N, Singh TG, Kaur A, Kaur G. Thapa K, et al. Among authors: kanojia n. Eur J Pharmacol. 2022 Sep 5;930:175133. doi: 10.1016/j.ejphar.2022.175133. Epub 2022 Jul 2. Eur J Pharmacol. 2022. PMID: 35792170 Review.

5

COVID-19-Associated acute respiratory distress syndrome (CARDS): Mechanistic insights on therapeutic intervention and emerging trends.

Thapa K, Verma N, Singh TG, Kaur Grewal A, Kanojia N, Rani L. Thapa K, et al. Among authors: kanojia n. Int Immunopharmacol. 2021 Dec;101(Pt A):108328. doi: 10.1016/j.intimp.2021.108328. Epub 2021 Nov 3. Int Immunopharmacol. 2021. PMID: 34768236 Free PMC article.

6

Formulation development and optimization of fast dissolving tablets of aceclofenac using natural superdisintegrant.

Kaur L, Bala R, Kanojia N, Nagpal M, Dhingra GA. Kaur L, et al. Among authors: kanojia n. ISRN Pharm. 2014 May 8;2014:242504. doi: 10.1155/2014/242504. eCollection 2014. ISRN Pharm. 2014. PMID: 24944837 Free PMC article.

7

Human genetic factors associated with pneumonia risk, a cue for COVID-19 susceptibility.

Guin D, Yadav S, Singh P, Singh P, Thakran S, Kukal S, Kanojia N, Paul PR, Pattnaik B, Sardana V, Grover S, Hasija Y, Saso L, Agrawal A, Kukreti R. Guin D, et al. Among authors: kanojia n. Infect Genet Evol. 2022 Aug;102:105299. doi: 10.1016/j.meegid.2022.105299. Epub 2022 May 8. Infect Genet Evol. 2022. PMID: 35545162 Free PMC article.

8

Effect of Oxidative Stress on ABC Transporters: Contribution to Epilepsy Pharmacoresistance.

Grewal GK, Kukal S, Kanojia N, Saso L, Kukreti S, Kukreti R. Grewal GK, et al. Among authors: kanojia n. Molecules. 2017 Feb 27;22(3):365. doi: 10.3390/molecules22030365. Molecules. 2017. PMID: 28264441 Free PMC article. Review.

9

Systems Approach to Identify Common Genes and Pathways Associated with Response to Selective Serotonin Reuptake Inhibitors and Major Depression Risk.

Srivastava A, Singh P, Gupta H, Kaur H, Kanojia N, Guin D, Sood M, Chadda RK, Yadav J, Vohora D, Saso L, Kukreti R. Srivastava A, et al. Among authors: kanojia n. Int J Mol Sci. 2019 Apr 23;20(8):1993. doi: 10.3390/ijms20081993. Int J Mol Sci. 2019. PMID: 31018568 Free PMC article.

10

Multidrug efflux transporter ABCG2: expression and regulation.

Kukal S, Guin D, Rawat C, Bora S, Mishra MK, Sharma P, Paul PR, Kanojia N, Grewal GK, Kukreti S, Saso L, Kukreti R. Kukal S, et al. Among authors: kanojia n. Cell Mol Life Sci. 2021 Nov;78(21-22):6887-6939. doi: 10.1007/s00018-021-03901-y. Epub 2021 Sep 29. Cell Mol Life Sci. 2021. PMID: 34586444 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

21 results

Search Page